John B. Moriarty
CIK: 0001564621
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 17, 2026KARD
Kardigan, Inc.
Award(A)Direct47.8K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
Disposition(D)Direct92.1K shares- - Jan 7, 2026RNA
Avidity Biosciences, Inc.
Sale(S)Direct2.4K shares at avg. $72.23$171K - Dec 17, 2025RNA
Avidity Biosciences, Inc.
Award(A)Direct56K shares- - Dec 17, 2025RNA
Avidity Biosciences, Inc.
Tax Payment(F)Direct26.8K shares at avg. $71.87$1.9M - Aug 4, 2025RNA
Avidity Biosciences, Inc.
Sale(S)Direct2.2K shares at avg. $36.21$81K - Jan 6, 2025RNA
Avidity Biosciences, Inc.
Award(A)Direct25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  KARD Kardigan, Inc. | Award(A) | 47,784 | - | $0 | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition(D) | 92,054 | - | $0 | Direct |
| Jan 7, 2026 |  RNA Avidity Biosciences, Inc. | Sale(S) | 2,374 | $72.23 | $171,474 | Direct |
| Dec 17, 2025 | RNA Avidity Biosciences, Inc. | Award(A) | 56,000 | - | - | Direct |
| Dec 17, 2025 | RNA Avidity Biosciences, Inc. | Tax Payment(F) | 26,824 | $71.87 | $1,927,841 | Direct |
| Aug 4, 2025 | RNA Avidity Biosciences, Inc. | Sale(S) | 2,245 | $36.21 | $81,291 | Direct |
| Jan 6, 2025 | RNA Avidity Biosciences, Inc. | Award(A) | 25,000 | - | $0 | Direct |
1-7 of 7 transactions
About Moriarty John B
Moriarty John B (SEC CIK 0001564621) files insider reports with the SEC as Chief Legal Officer of Kardigan, Inc. (KARD) and Chief Legal Officer of Avidity Biosciences, Inc. (RNAM).
Signal8 holds 7 ownership filings by Moriarty John B (1 Form 3, 6 Form 4), filed between Jan 8, 2025 and Jun 22, 2026. Those filings report 7 transactions, from Jan 6, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Moriarty John B's filings is in PRINCETON, NJ.
Recent filings by Moriarty John B
- Jun 17, 2026: Grant or award of KARD shares (Form 4, code A).
- Feb 27, 2026: Disposition to issuer transaction of RNAM shares (Form 4, code D).
- Jan 7, 2026: Open-market sale of RNA shares (Form 4, code S).
- Dec 17, 2025: Grant or award of RNA shares (Form 4, code A).
- Dec 17, 2025: Tax withholding of RNA shares (Form 4, code F).
Other insiders filing for Kardigan, Inc. (KARD)
- Reinke Kristin Marie K, Director
- PERCEPTIVE ADVISORS LLC, Director
- HRTG GPE, LLC, 10% Owner
- BERNS PAUL L, Director
- ARCH Venture Partners XIII, LLC, Director
- Pasternak Andy, Chief Strategy Officer